Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOOSTCAMP CBD pre-treatment for anxiety symptoms
NL-OMON60673Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cannabidiol in anxiety disorder and post-traumatic stress disorder (PTSD), sponsored by University Medical Center Utrecht. Started Oct 2024; status: completed.
02
Drugs
cannabidiol
03
Conditions
anxiety disorderpost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NL-OMON60673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60673.